Replimune
Develops immunotherapies for cancer treatment
Total raised
€27M
€27,272,727
Funding rounds
1
Investors
2
distinct backers
Active since
2015-08
latest 2015-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series A | €27M | Atlas Venture,Forbion Capital Partners | View deal → |